SOLICITATION NOTICE
70 -- Renewal of Ingenuity Pathway Analysis & Training
- Notice Date
- 8/3/2016
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Jefferson, 3900 NCTR Road, HFT-320, Bldg 50 | Rm 421, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- fDA-SOL-1169074A
- Archive Date
- 8/27/2016
- Point of Contact
- Karen L Conroy, Phone: 781-587-7452
- E-Mail Address
-
kconroy@ora.fda.gov
(kconroy@ora.fda.gov)
- Small Business Set-Aside
- N/A
- Description
- Synopsis: This is a combined synopsis/ solicitation for renewal of software in accordance with FAR Regulation (FAR) 12.102(g) and in the format of Subpart 12.6 and 13.5 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation. Quotations are being requested and a written solicitation will not be issued. The solicitation number is FDA- SOL –16-1169074A- and is issued as a Request for Proposals (RFP). This solicitation document incorporated all mandatory commercial item provision and clauses that are in effect through the Federal Acquisition Circular 2005- 89 dated 7/14/2016. The North American Industrial Classification System is 541711and the small size standard is 35M 500L This is a firm fixed price contract and is being issued as a “Brand Name or Equal to”. If equal items are proposed, the quoter shall provide product specifications for those items proposed. All products proposed (whether brand name listed or equal to items proposed) must satisfy the functional requirements/salient characteristics set forth in this document. Title : Renewal of Ingenuity Pathway Analysis Software and training 1.0 Background Background: The Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR) staff engaged in research in bioinformatics, genomics, proteomics, and metabolomics require highly specialized software for biological pathway and molecular network analysis and biomarker discovery. Ingenuity Pathway Analysis (IPA) software is used throughout the FDA and was purchased for use at NCTR in August 22, 2012 under contract HHSF223201210923P. NCTR holds two, one-concurrent licenses of IPA software and requires annual license renewal to continue to support the pathway analysis and molecular network research at NCTR and the regulatory science needs of the FDA. The FDA Information Technology Ingenuity Pathway Analysis Software and is identified on the Master Approved Technology (MAT) list as approval IM084956. 2.0 Objective Objective: Renewal of two existing, one-concurrent user licenses for Ingenuity Pathway Analysis Software and training. 3.0 Scope Licenses for Ingenuity Pathway Analysis Software are required to continue to support the pathway analysis and molecular network research at NCTR and the regulatory science needs of the FDA. The FDA intends to award a Firm Fixed price contract to meet the requirements of this solicitation. 4.0 Deliverables 4.1Renewal of two existing, one-concurrent user licenses for Ingenuity Pathway Analysis Software - The licenses for the application must allow for creation of two user groups. The groups shall be independent (i.e., users from one group will not utilize the license for the other group) - The licenses must be concurrent and not tied to named users or computers 4.2 Onsite training: - The vendor shall provide one day of onsite training at the NCTR campus located in Jefferson, Arkansas - Training shall cover accessing and operating the software, including all major analytical functions and workflows, and include question and answer sessions - Vendor shall provide training materials for the class - The training shall be scheduled on a date mutually agreeable to the vendor and the NCTR point of contact - Training shall begin no later than 10:00 A.M. Central time, be completed no later than 4:00 P.M. Central time and span not less than 4 hours of actual instruction. A one hour break for lunch shall be provided - Onsite training shall be provided no later than 60 calendar days after award An example of a product that meets our needs is as follows: Item#1 #830076 IPA with Advanced Analytics 2 each Item#2 #830500 One day on site IPA training of Performance: 1 each 5.0 Place of Performance The licenses must be concurrent and not tied to named users or computers. License renewal may be delivered electronically, for use at: US Food and Drug Administration National Center for Toxicological Research 3900 NCTR Road Jefferson, AR 72079 6.0 Period of Performance: One year: August 22, 2016 – August 21, 2017; and on-site training for user groups no later than 60 calendar days after award 7.0 Evaluation Criteria The Government will select the bidder whose offer best conforms to the solicitation and is most advantageous and provides the best value to the Government. The ability to provide the requested chemical simulation software and support is the most important factor. If proposals are equal in their technical merit, lowest price will become the determining factor. 8.0 Other Pertinent Information or Special Considerations 8.1 Section 508 The following HHSR clause applies to this task order: HHSR 352.239-73 Electronic and Information Technology Accessibility (January 2010) Pursuant to Section 508 of the Rehabilitation Act of 1973 ( 29 U.S.C. 794d ) as amended by Public Law 105–220 under Title IV (Rehabilitation Act Amendments of 1998), all Electronic and Information Technology (EIT) developed, procured, maintained, and/or used under this contract shall be in compliance with the ‘‘Electronic and Information Technology Accessibility Standards’’ set forth by the Architectural and Transportation Barriers Compliance Board (also referred to as the ‘‘Access Board’’) in 36 CFR part 1194. The complete text of Section 508 Final Standards can be accessed at http://www.access-board.gov/sec508/standards.htm. The standards applicable to this requirement are: Subpart B -- Technical Standards § 1194.21 Software applications and operating systems. (a) When software is designed to run on a system that has a keyboard, product functions shall be executable from a keyboard where the function itself or the result of performing a function can be discerned textually. (b) Applications shall not disrupt or disable activated features of other products that are identified as accessibility features, where those features are developed and documented according to industry standards. Applications also shall not disrupt or disable activated features of any operating system that are identified as accessibility features where the application programming interface for those accessibility features has been documented by the manufacturer of the operating system and is available to the product developer. (c) A well-defined on-screen indication of the current focus shall be provided that moves among interactive interface elements as the input focus changes. The focus shall be programmatically exposed so that assistive technology can track focus and focus changes. (d) Sufficient information about a user interface element including the identity, operation and state of the element shall be available to assistive technology. When an image represents a program element, the information conveyed by the image must also be available in text. (e) When bitmap images are used to identify controls, status indicators, or other programmatic elements, the meaning assigned to those images shall be consistent throughout an application's performance. (f) Textual information shall be provided through operating system functions for displaying text. The minimum information that shall be made available is text content, text input caret location, and text attributes. (g) Applications shall not override user selected contrast and color selections and other individual display attributes. (h) When animation is displayed, the information shall be displayable in at least one non-animated presentation mode at the option of the user. (i) Color coding shall not be used as the only means of conveying information, indicating an action, prompting a response, or distinguishing a visual element. (j) When a product permits a user to adjust color and contrast settings, a variety of color selections capable of producing a range of contrast levels shall be provided. (k) Software shall not use flashing or blinking text, objects, or other elements having a flash or blink frequency greater than 2 Hz and lower than 55 Hz. (l) When electronic forms are used, the form shall allow people using assistive technology to access the information, field elements, and functionality required for completion and submission of the form, including all directions and cues. Subpart C -- Functional Performance Criteria § 1194.31 Functional performance criteria. (a) At least one mode of operation and information retrieval that does not require user vision shall be provided, or support for assistive technology used by people who are blind or visually impaired shall be provided. (b) At least one mode of operation and information retrieval that does not require visual acuity greater than 20/70 shall be provided in audio and enlarged print output working together or independently, or support for assistive technology used by people who are visually impaired shall be provided. (c) At least one mode of operation and information retrieval that does not require user hearing shall be provided, or support for assistive technology used by people who are deaf or hard of hearing shall be provided. (d) Where audio information is important for the use of a product, at least one mode of operation and information retrieval shall be provided in an enhanced auditory fashion, or support for assistive hearing devices shall be provided. (e) At least one mode of operation and information retrieval that does not require user speech shall be provided, or support for assistive technology used by people with disabilities shall be provided. (f) At least one mode of operation and information retrieval that does not require fine motor control or simultaneous actions and that is operable with limited reach and strength shall be provided. Subpart D -- Information, Documentation, and Support § 1194.41 Information, documentation, and support. (a) Product support documentation provided to end-users shall be made available in alternate formats upon request, at no additional charge. (b) End-users shall have access to a description of the accessibility and compatibility features of products in alternate formats or alternate methods upon request, at no additional charge. (c) Support services for products shall accommodate the communication needs of end-users with disabilities. 8.2 Other provisions and clauses FAR 52.211-6 Brand Name or Equal Clauses and provisions are incorporated by reference and apply to this acquisition. Responses to this notice must be sent via email to Karen.conroy@fda.hhs.gov. No phone calls will be accepted. 9.0 Instruction to Quoters Quoters shall comply with the provision at FAR52.212-1(b) and submit an electronic copy to Karen Conroy. The Quoter shall submit a technical volume and a pricing volume. Each volume should include the information specified below: Volume One · Demonstrates the Quoters capability to meet each requirement as described in the Statement of Work. · Volume one shall not exceed five pages describing how they can perform. Volume Two Quoters shall include a completed copy of the provision FAR 52-212-3 Offeror Representations and Certifications- Commercial Items (March 2015) which can be accessed electronically from the INTERNET at the following address: http://farsite.hill.af.mil/. Quoters responding to this RFP must be registered with the System for Award Management (SAM), hht://www.sam.gov. FAR 52-212-4 Contract Terms and Conditions- Commercial Item (May 2015) and FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (May 2015, applies as follows: 52.233.-3, 52.233-4, 52.203-6, 52.219-6, 52.219-8, 52.222-3, 52.222-21, 52.222-26, 52-222-35, 52.222-36, 52.222-37 52.225-13, 52.232-33. and 52.239-1. FAR provisions and clauses may be found at http://www.acquistiion.gov/far/index.html Quoters that can provide and meet the above requirements shall submit a written quotation. Submission must be received via email no later than ( August 12, 2016 2:30pm eastern time). Questions shall be received no later than (August 9, 2016. @ 3:00pmeastern time). Unlimited number of pages 9.0 Point of Contact Karen Conroy One Montvale Ave., 4 th floor Stoneham, MA 02180 781-587-7452 karen.conroy@fda.hhs.gov
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/fDA-SOL-1169074A/listing.html)
- Place of Performance
- Address: U.S. Food & Drug Administration/ NCTR, 3900 NCTR Road, Jefferson AR. 72079, Jefferson, Arkansas, 72079, United States
- Zip Code: 72079
- Zip Code: 72079
- Record
- SN04207917-W 20160805/160803235409-bf32d0498497280ac519fc121b50d268 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |